Eland Private Equity launches Korion Life Sciences, fund of funds with focus on the US, Europe and Israel
Eland Private Equity lanza Korion Life Sciences, fondo de fondos con el foco en Estados Unidos, Europa e Israel
Intel ID : 352321
|
||||
| Intel ID | 352321 | |
| Value | ND | |
| Native Currency | Euro (EUR) | |
|
Financial Data - Eland Private Equity
(31 Dec 2022) |
Revenue: EUR 0,88m EBITDA: EUR 0,01m Net Debt: EUR 4,76m People: 6 |
|
| Date |
 |
|
| Country | |
|
| Geography |  |
|
| Subsector (Old TTR Sectors) |
|
|
| Primary Subsector (TTRSC) |
25.01.09 Private Equity (Primary) 25 Financial Services / 25.01 Banking & Investment |
|
| Type |
|
|
| Intel Grade |
|
|
| Source |
|
|
| Tags | |
Bidder
| Name |
|
||
| Subsector (Old TTR Sectors) |
|
||
| Primary Sector (TTRSC) |
25.01.09 Private Equity 25 Financial Services / 25.01 Banking & Investment |
||
| Country |
|
||
| Website |
|
||
| Description |
|
Ultimate Owner (Buyer)
| Name |
|
||
| Subsector (Old TTR Sectors) |
|
||
| Primary Sector (TTRSC) |
25.01.09 Private Equity 25 Financial Services / 25.01 Banking & Investment |
||
| Country |
|
||
| Website |
|
||
| Description |
|
Legend:
Verified: Confirmed as a party to an active or possible transaction.
Potential: Unconfirmed as a party to an active or possible transaction.
Retained: Confirmed as “Retained” with a general or specific mandate.
Prospect: Advisory “Prospect” in discussions with or pitching services to possible client.
Transactional data is continuously updated by the research team and therefore is subject to change.